Topical Acne Composition Manufacturing via Dual Homogenization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current acne treatments, including antibiotics and retinoids, face challenges such as skin irritation, resistance development, slow results, and aesthetic issues, which affect compliance and efficacy, and there is a need for compositions that address all four pathogenic factors of acne without significant adverse effects.
Innovation Solution
A method of manufacturing pharmaceutical compositions involves homogenizing a first excipient composition with a viscosity agent and solvent, and separately homogenizing an active pharmaceutical ingredient with a second excipient composition, then combining them to form a stable and uniform topical composition, using a moisture and/or oxygen-controlled homogenization apparatus to enhance stability and reduce irritation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current acne treatments (antibiotics and retinoids) are used, then acne pathogenic factors are addressed, but skin irritation and adverse effects occur
Solution Approach 1:
The treatment is divided into multiple components applied at different times (morning and evening routines with different formulations), allowing each component to target specific pathogenic factors while minimizing irritation from any single agent
Solution Approach 2:
The patent modifies treatment parameters by using different vehicles, concentrations, and application frequencies for different components, optimizing effectiveness while reducing adverse effects through controlled delivery
2Duration of action of moving object
If protracted treatment periods are used, then acne pathology is addressed, but resistance development occurs
Solution Approach 1:
The patent combines multiple antimicrobial agents with different mechanisms of action in a coordinated treatment regimen, preventing resistance by targeting bacteria through multiple pathways simultaneously and sequentially
Solution Approach 2:
The treatment employs periodic application schedules with varying concentrations and combinations of agents, creating fluctuating selective pressure that prevents adaptive resistance while maintaining therapeutic efficacy
3Reliability
If topical treatments are applied, then acne lesions are treated, but cosmetic elegance and compliance are reduced
Solution Approach 1:
Different formulations are designed with specific local properties (texture, finish, absorption rate) optimized for their intended use time and skin condition, improving patient acceptance while maintaining therapeutic effectiveness
Solution Approach 2:
The treatment regimen is dynamically structured with varying application schedules and formulations based on skin condition and time of day, allowing optimization of both efficacy and cosmetic properties at different stages
Data Source
AI summary
Provided according to some embodiments of the invention are methods of manufacturing a pharmaceutical composition. In some embodiments, such methods include homogenizing at a first excipient composition that includes a viscosity agent and at least one solvent to form a first premix composition; separately homogenizing at least one active pharmaceutical ingredient (API) and a second excipient composition to form a second premix composition; and combining the first premix composition and the second premix composition to form the composition. The pre-mixing of constituents may increase the stability of the API and provide uniformity of the dispersion of the constituents throughout the final topical composition.